Clinical Study
The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes
Table 1
Demographic features, indication for EGD, and EGD findings of patients with intestinal metaplasia.
| | () |
| Sex | | Male | 227 (40.5%) | Female | 333 (59.5%) | Age (years) | 57.0 ± 15.3 (17–98) | Age groups | | <31 | 29 (5.2%) | 31–40 | 56 (10%) | 41–50 | 115 (18.8%) | 51–60 | 144 (25.7%) | 61–70 | 113 (20.2%) | 71–80 | 87 (15.5%) | >80 | 26 (4.6%) | Indication for EGD | | Dyspepsia | 231 (41.2%). | Abdominal pain | 145 (25.9%) | GERD | 75 (13.4%) | Cancer screening | 29 (5.2%) | Others | 80 (14.3%) | EGD findings | | Gastritis (nonerosive, erosive, atrophic, etc) | 378 (67.5%) | Gastric ulcer | 34 (6.1%) | Gastric cancer | 22 (3.9%) | Others | 126 (22.5%) |
|
|
GERD: gastroesophageal reflux disease; EGD: esophagogastroduodenoscopy.
|